Putnam Investments’s Chimerix, Inc. CMRX Stock Holding History

Putnam Investments’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-78,394	Closed	-$359K	–	1234
2022 Q1	$359K	Sell	78,394 -5,590	-7%	-$31.2K	﹤0.01%	1098
2021 Q4	$540K	Buy	+83,984	New	+$504K	﹤0.01%	959
2015 Q4	–	Sell	-23,490	Closed	-$897K	–	1498
2015 Q3	$897K	Sell	23,490 -76,710	-77%	-$3.79M	﹤0.01%	1195
2015 Q2	$4.63M	Buy	100,200 +500	+0.5%	+$20K	0.01%	759
2015 Q1	$3.76M	Hold	99,700	–	–	0.01%	870
2014 Q4	$4.01M	Hold	99,700	–	–	0.01%	834
2014 Q3	$2.75M	Sell	99,700 -600	-0.6%	-$14.6K	0.01%	942
2014 Q2	$2.2M	Hold	100,300	–	–	﹤0.01%	1010
2014 Q1	$2.29M	Buy	100,300 +300	+0.3%	+$6.05K	0.01%	1017
2013 Q4	$1.51M	Hold	100,000	–	–	﹤0.01%	1118
2013 Q3	$2.2M	Hold	100,000	–	–	0.01%	1035
2013 Q2	$2.42M	Buy	+100,000	New	+$2.09M	0.01%	984

Other funds holding CMRX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Putnam Investments's CMRX Position: Q2 2022 in Review

Putnam Investments sold out of Chimerix, Inc. (CMRX) in Q2 2022, closing a stake of 78,394 shares — an estimated $359K sold.

Putnam Investments first reported a position in CMRX in Q2 2013 and held it in 12 quarters. The position peaked at $4.63M in Q2 2015. 117 funds tracked by Wall St. Rank hold CMRX as of Q2 2022.

Putnam Investments reported no remaining Chimerix, Inc. position as of Q2 2022 after selling out during the quarter.
Putnam Investments sold 78,394 Chimerix, Inc. shares in Q2 2022, an estimated $359K.
Putnam Investments first reported a position in Chimerix, Inc. in Q2 2013 and held it in 12 quarters.
Putnam Investments's Chimerix, Inc. position peaked at $4.63M in Q2 2015.
117 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.